Scientist, Molecular Bioanalysis
Labcorp
Greenfield, Indiana
Labcorp Molecular Bioanalysis – Method Development Senior Scientist
Dr. Rennier has over 15+ years of biomedical research and development expertise in PCR, cell-based assays, signal transduction pathways and flow cytometry. His research has primarily focused on cellular mechanotransduction, tumor immunology and cancer biology.
He earned a PhD in Biomedical Engineering from Purdue University in 2015.
As a postdoctoral research fellow at Washington University in St. Louis, Dr. Rennier focused on assay development to delineate key oncogenic signaling pathways, immunotherapy response and immune cell recruitment in human tumors.
After fellowship, he joined Labcorp in 2020. Currently working as part of the Molecular Bioanalysis group, Dr. Rennier serves as a Senior Scientist/Manager, Global Molecular BioA SME, and a scientific point of contact for internal and external GLP/GCP projects based out of the Greenfield, IN. Dr. Rennier maintains an overarching focus on scientific innovation and provides oversight to ensure the successful development, validation, and execution of pre-clinical and clinical stage bioanalysis studies.
Disclosure information not submitted.
Molecular Bioanalysis Considerations for Transitioning from Pre-clinical to the Clinical Space
Tuesday, May 6, 2025
9:15 AM - 10:00 AM ET